New York State Department of Health
Genetic Susceptibility to Breast and Ovarian Cancer:
Assessment, Counseling and Testing Guidelines
Return to Cancer Guidelines

APPENDIX XIII:    GENETIC TESTING LABORATORIES APPROVED TO PROVIDE DNA-BASED ANALYSIS FOR GENETIC/CANCER PREDISPOSITION TESTING FOR SPECIMENS ORIGINATING IN NYS

Disease: Hereditary Breast Cancer

Genes: BRCA1 and BRCA2

Clinical laboratory testing of New York State residents must be performed by appropriately licensed laboratories. The current status of a laboratory's licensure should be verified with the New York State Department of Health, Clinical Laboratory Evaluation Program, 518-485-5378 or the Genetic Testing Quality Assurance Program, 518-474-6796.

DNA-based testing for Genetic/Cancer Predisposition is considered by the New York State Department of Health to be an investigational procedure.

Laboratories that screen for specific mutations within the BRCA1 and BRCA2 genes are recommended to perform gene sequence analysis whenever negative test results are obtained for a patient.

Mark Rabin, Ph.D.
OncorMed, Inc.
205 Perry Parkway
Gaithersburg, MD 20877
301-208-1888

Brian Ward, PhD.
Myriad Genetic Laboratories
320 Wakara Way
Salt Lake City, UT 84108
801-584-1100

Mary-Claire King, Ph.D.
King Laboratory, University of Washington
K160 Health Sciences Center
Seattle, WA 98195-7720
206-616-4294

Fred Gilbert, MD
DNA Diagnostic Laboratory
Cornell University School of Medicine
515 East 71 Street, Room 5-608
New York, NY 10021
212-746-3475

Robert J. Desnick, M.D., Ph.D.
Mt. Sinai Medical Center
Genetic Testing Laboratory
One Gustave Levy Place
Box 1203
New York, NY 10029-6574
212-241-6944

Nathan A. Ellis, Ph.D.
Diagnostic Molecular Genetics Laboratory
Memorial Sloan-Kettering Cancer Center
1275 York Avenue
New York, NY 10021
212-639-5151

October 1998


Send questions or comments to: brcpg@health.state.ny.us
Revised: October 1999

What'sThis Month / HELP! / Search our Website